Diagnostic Workup and Treatment for Suspected PCOS
Diagnose PCOS using the Rotterdam criteria, requiring at least two of three features: clinical or biochemical hyperandrogenism, ovulatory dysfunction (cycles >35 days), or polycystic ovarian morphology on ultrasound (≥20 follicles per ovary or ovarian volume ≥10mL). 1, 2, 3
Clinical History Assessment
Document the following specific elements:
- Menstrual pattern: Record exact cycle length and regularity, as cycles >35 days indicate chronic anovulation 1, 2
- Androgen excess timeline: Note whether hirsutism, acne, or alopecia developed gradually (suggests PCOS) versus rapidly (suggests androgen-secreting tumor) 1, 2
- Medication review: Specifically ask about exogenous androgen use 1, 2
- Lifestyle factors: Document diet quality, exercise frequency, alcohol consumption, and smoking status 1, 2
- Family history: Record cardiovascular disease, diabetes, and reproductive disorders in first-degree relatives 1, 2
Physical Examination
Perform targeted assessment for:
- Hyperandrogenism signs: Evaluate acne distribution, male-pattern balding (temporal recession), hirsutism using standardized scoring, and clitoromegaly 1, 2
- Insulin resistance markers: Look for acanthosis nigricans (neck, axillae, groin) 1, 2
- Body measurements: Calculate BMI and waist-hip ratio 1, 2
- Cushing's syndrome screening: Check for buffalo hump, moon facies, and wide purple abdominal striae 1
- Pelvic examination: Assess for ovarian enlargement 1
Laboratory Testing
Order the following tests to confirm diagnosis and exclude mimicking disorders:
Hormonal Evaluation
- Total testosterone or free/bioavailable testosterone: Use mass spectrometry method to document hyperandrogenism 1, 2
- Sex hormone-binding globulin (SHBG): Helps calculate free androgen index 1
- TSH: Exclude thyroid disease as cause of menstrual irregularity 1, 2
- Prolactin: Rule out hyperprolactinemia 1, 2
- 17-hydroxyprogesterone: Exclude nonclassic congenital adrenal hyperplasia 2
Metabolic Evaluation
- 2-hour oral glucose tolerance test with 75g glucose load: Screen all PCOS patients regardless of BMI for type 2 diabetes and glucose intolerance 1, 2
- Fasting lipid profile: Assess total cholesterol, LDL, HDL, and triglycerides 1, 2
Imaging Studies
Use transvaginal ultrasound as first-line imaging with an 8MHz or higher transducer. 1, 2
- Follicle count: Look for ≥20 follicles measuring 2-9mm per ovary (note: recent evidence suggests ≥20 follicles, though some sources cite ≥25) 4, 1
- Ovarian volume: Measure three dimensions of each ovary; ≥10mL suggests polycystic ovarian morphology 4, 1, 2
- Alternative imaging: Use transabdominal ultrasound focusing on ovarian volume ≥10mL threshold when transvaginal approach is not feasible 1, 2
- MRI pelvis without contrast: Consider when ovaries cannot be adequately visualized by ultrasound 4, 1
Important caveat: Ultrasound findings alone are insufficient for diagnosis, as polycystic ovarian morphology may be present in up to one-third of reproductive-aged women without PCOS. 4, 1
Diagnostic Algorithm
- Confirm at least two Rotterdam criteria are present: hyperandrogenism (clinical or biochemical), ovulatory dysfunction, and/or polycystic ovarian morphology 2, 3
- Exclude alternative diagnoses through targeted testing: thyroid disease, hyperprolactinemia, nonclassic congenital adrenal hyperplasia, Cushing's syndrome, androgen-secreting tumors, acromegaly, and primary ovarian failure 1, 2
- Document the specific phenotype (1 of 4 recognized phenotypes) as this has different long-term health implications 5
Treatment Approach
Treatment depends on the patient's primary concerns and goals:
For Menstrual Irregularities and Hyperandrogenism
Hormonal contraceptives are first-line therapy for menstrual abnormalities, hirsutism, and acne. 3
For Infertility
Clomiphene is first-line therapy for ovulation induction. 3
For Metabolic Abnormalities
Metformin is beneficial for metabolic/glycemic abnormalities and improving menstrual irregularities, but has limited benefit for hirsutism, acne, or infertility. 3
For Overweight/Obese Patients
Lifestyle intervention with diet modification and increased physical activity is beneficial for metabolic health, though its role in improving PCOS status per se remains uncertain. 3, 6
Critical Pitfalls to Avoid
- Do not use serum AMH levels as a single diagnostic test despite emerging evidence 1
- Do not diagnose PCOS based on ultrasound findings alone given high prevalence of polycystic ovarian morphology in normal women 4, 1
- Monitor for endometrial cancer risk in patients with chronic anovulation, particularly those with obesity and hyperinsulinemia 1, 2
- Avoid using ovarian ultrasonography in adolescents <8 years post-menarche due to high incidence of polycystic ovarian morphology during normal development 4
- Screen for associated conditions: glucose intolerance, type 2 diabetes, dyslipidemia, hypertension, hepatic steatosis, obstructive sleep apnea, and mood disorders 5, 3